Intervention Review

Dopaminergic agonists for hepatic encephalopathy

  1. Bodil Als-Nielsen1,*,
  2. Lise Lotte Gluud2,
  3. Christian Gluud2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 23 AUG 2004

DOI: 10.1002/14651858.CD003047.pub2

Database Title

Additional Information

How to Cite

Als-Nielsen B, Gluud LL, Gluud C. Dopaminergic agonists for hepatic encephalopathy. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003047. DOI: 10.1002/14651858.CD003047.pub2.

Author Information

  1. 1

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Bodil Als-Nielsen, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Dept. 3344, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. bodil.als@dadlnet.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (270K)Full (325K)

  1. Current Version

    Dopaminergic agonists for hepatic encephalopathy

    Bodil Als-Nielsen, Lise Lotte Gluud and Christian Gluud

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD003047.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Dopaminergic agonists for hepatic encephalopathy

    B Als-Nielsen, LL Kjaergard and C Gluud

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD003047

View Full Article (HTML) Summary (59K)Standard (270K)Full (325K)